Phynova Group Ltd Product Pipeline Review 2012 New Report


Naperville, IL -- (SBWIRE) -- 12/18/2012 -- Phynova Group Ltd - Product Pipeline Review - 2012 provides data on the Phynova Group Ltd’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.


- Phynova Group Ltd - Brief Phynova Group Ltd overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Phynova Group Ltd human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Phynova Group Ltd with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Phynova Group Ltd’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Phynova Group Ltd’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Phynova Group Ltd in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Phynova Group Ltd’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Phynova Group Ltd.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Phynova Group Ltd and identify potential opportunities in those areas.

To view table of contents for this market report please visit: